SKIN

SkinHealth Systems Inc. Class A Common Stock (SKIN) | Rumor.io

SkinHealth Systems

SKIN

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)100%

Price to earnings ratio-8.12

Market capitalization84.6M

Earnings per share-0.23

Dividend yield (TTM)—

Revenue (annual)300.8M

Net income (annual)-9.5M

Social

What share of all stock conversation is about SKIN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jul 8

Fidelity now owns 10,201,685 shares of $SKIN, representing 7.9% of the company, indicating continued support for the stock.
The FDA clearance, $200 million in financing, and convertible notes converting above the current share price are positive factors supporting the longer-term thesis for $SKIN.
The stock needs a catalyst or a jolt of momentum to break out, with possible breakout points being discussed but not specified.

Generated by AI

Sentiment

Of the messages about SKIN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	89.28% -4.27
Bearish	—	—	—	10.72% +4.27

Bullish· Jul 7

$SKIN has expanded its FDA-cleared SkinStylus platform into a large market for wrinkle treatment, presenting a broader commercial opportunity.
The company's narrative is changing, potentially leading to a turnaround story as Wall Street catches up with the expansion.
$SKIN has a short interest of 26% of its float, potentially setting up a squeeze scenario.

Bearish· Nov 14

The Beauty Health Company, owner of the $SKIN ticker, has reported worse-than-expected Q3 financial results and revised guidance, leading to a significant share price drop.
The company's recent financial performance has been deemed "not acceptable" by the CFO, with the company lowering sales guidance and shaking up management, including the departure of CEO Andrew Stanleick.
The company's valuation is considered low, with some analysts suggesting that it is valued at only ~1x its high-margin consumable revenue, despite a significant decline in share price.

Generated by AI

Topics

Of the messages about SKIN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	—	21.14%
Macro	—	—	—	1.14%
Announcements	—	—	—	11.43%
Analysts	—	—	—	33.14%
Controversies	—	—	—	0%
Earnings	—	—	—	33.14%

Feb 28

The Beauty Health Company (SKIN) reported Q4 FY 2022 earnings, with net sales of $98.1M, beating estimates, and adjusted EBITDA of $16.3M, up 92% YoY.
SKIN announced plans to acquire SkinStylus, a FDA-cleared microneedling device, which is expected to be accretive in FY24.
SKIN's FY23 initial guide is $450-470M in revenue, above street estimates, and maintains prior long-term growth targets.

Generated by AI

Community

Of the messages about SKIN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	15.58%
Newcomers	—	—	—	84.42%

Regulars· Mar 13

The Beauty Health Company's shares are trading near $5 after earnings showed progress on quality issues and resilient consumable volumes, with a notable increase in share buybacks and debt conversion.
The company's pre-market price is up 20.33%, with trading volume 415% above average, and the stock is up 24.76%.
The Beauty Health Company reported mixed 2023 financial results, with an operating deficit of $18.36 million, amidst global expansion efforts.

Newcomers· Mar 13

The newcomer is excited about the possibility of a short squeeze in $SKIN, citing the number of shorts and puts bought ahead of earnings.
The newcomer claims to have a 90%+ correct public record and encourages others to get in on the trade, advising to give it time to work.
The newcomer is focused on the robust Q4 revenue growth of $SKIN, which led to a 19% surge in the stock price.

Generated by AI

New York, NY, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Gen Z and Millennial men are subscribing more and spending more time and money on BHW than any other demographicThe beauty industry is ignoring what women actually want—and leaving billions on the table in the processPhysicians are second-most important referral channel behind friends and family; influencers rank lastThe pharmification effect: GLP-1s have changed expectations for time to results for all categories of BHWThe medspas explosion: Near

1d agoYahoo Finance UK

Why more companies are fighting over consumers' beauty, health and wellness spending

As consumers prioritize holistic retail purchases, beauty, health and wellness are increasingly converging into one category and one consumer budget.

12d agoCNBC

Beauty Health Elevates Monahan to Finance and Operations Chief

Detailed price information for Skinhealth Systems Inc (SKIN-Q) from The Globe and Mail including charting and trades.

19d agoThe Globe and Mail

Beauty Health Q2 Earnings Call Highlights

1mo agoYahoo Finance

The Beauty Health Company Q2 2026 Earnings Call Summary

1mo agoYahoo Finance

Also Discussed

Investors talking about SKIN also mention

#	Name	Attention
1	Vintage Wine Estates, Inc.VWE	0%0
2	Bank of Akron (NY)BARK	0%0
3	InMode Ltd.INMD	0%0
4	Vivid Seats Inc. Class A Common StockSEAT	0%0
5	ATIP - ATI Physical Therapy, Inc.	——
6	Evolus Inc.EOLS	0%0
7	CarGurus Inc. Class A Common StockCARG	0%0
8	RVNC - Revance Therapeutics, Inc.	——
9	VHAQ - Viveon Health Acquisition Corp.	——
10	Genius Sports Ltd.GENI	0%new

SkinHealth Systems Inc. Class A Common Stock

Consumer Defensive
Household & Personal Products

SkinHealth Systems Inc. Class A Common Stock represents equity in SkinHealth Systems Inc., a global medical aesthetics company focused on professional skin-care and treatment technologies. SkinHealth Systems develops and markets an integrated portfolio centered on HydraFacial, its flagship skin treatment platform, alongside complementary offerings such as SkinStylus microneedling and HydraScalp with Keravive. The company serves clinics and providers through devices, consumables, and clinically validated treatment systems designed for use in aesthetic and dermatology-focused practices. Its products are distributed across multiple international regions, supporting a broad professional network in the skin-health market. SkinHealth Systems Inc. is headquartered in Long Beach, California, and its Class A Common Stock gives investors exposure to a business operating at the intersection of medical aesthetics, skincare technology, and provider-based treatment services.

Website

Location

2165 Spring Street

Long Beach, CA, 90806

United States

Social

What share of all stock conversation is about SKIN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jul 8

Fidelity now owns 10,201,685 shares of $SKIN, representing 7.9% of the company, indicating continued support for the stock.
The FDA clearance, $200 million in financing, and convertible notes converting above the current share price are positive factors supporting the longer-term thesis for $SKIN.
The stock needs a catalyst or a jolt of momentum to break out, with possible breakout points being discussed but not specified.

Generated by AI

Sentiment

Of the messages about SKIN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	89.28% -4.27
Bearish	—	—	—	10.72% +4.27

Bullish· Jul 7

$SKIN has expanded its FDA-cleared SkinStylus platform into a large market for wrinkle treatment, presenting a broader commercial opportunity.
The company's narrative is changing, potentially leading to a turnaround story as Wall Street catches up with the expansion.
$SKIN has a short interest of 26% of its float, potentially setting up a squeeze scenario.

Bearish· Nov 14

The Beauty Health Company, owner of the $SKIN ticker, has reported worse-than-expected Q3 financial results and revised guidance, leading to a significant share price drop.
The company's recent financial performance has been deemed "not acceptable" by the CFO, with the company lowering sales guidance and shaking up management, including the departure of CEO Andrew Stanleick.
The company's valuation is considered low, with some analysts suggesting that it is valued at only ~1x its high-margin consumable revenue, despite a significant decline in share price.

Generated by AI

Topics

Of the messages about SKIN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Technical Analysis	—	—	—	21.14%
Macro	—	—	—	1.14%
Announcements	—	—	—	11.43%
Analysts	—	—	—	33.14%
Controversies	—	—	—	0%
Earnings	—	—	—	33.14%

Feb 28

The Beauty Health Company (SKIN) reported Q4 FY 2022 earnings, with net sales of $98.1M, beating estimates, and adjusted EBITDA of $16.3M, up 92% YoY.
SKIN announced plans to acquire SkinStylus, a FDA-cleared microneedling device, which is expected to be accretive in FY24.
SKIN's FY23 initial guide is $450-470M in revenue, above street estimates, and maintains prior long-term growth targets.

Generated by AI

Community

Of the messages about SKIN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	15.58%
Newcomers	—	—	—	84.42%

Regulars· Mar 13

The Beauty Health Company's shares are trading near $5 after earnings showed progress on quality issues and resilient consumable volumes, with a notable increase in share buybacks and debt conversion.
The company's pre-market price is up 20.33%, with trading volume 415% above average, and the stock is up 24.76%.
The Beauty Health Company reported mixed 2023 financial results, with an operating deficit of $18.36 million, amidst global expansion efforts.

Newcomers· Mar 13

The newcomer is excited about the possibility of a short squeeze in $SKIN, citing the number of shorts and puts bought ahead of earnings.
The newcomer claims to have a 90%+ correct public record and encourages others to get in on the trade, advising to give it time to work.
The newcomer is focused on the robust Q4 revenue growth of $SKIN, which led to a 19% surge in the stock price.

Generated by AI

SkinHealth Systems

Social

Jul 8

Sentiment

Bullish· Jul 7

Bearish· Nov 14

Topics

Feb 28

Community

Regulars· Mar 13

Newcomers· Mar 13

News

New research reveals a great divide in beauty, health & wellness, with executives and consumers at odds

Why more companies are fighting over consumers' beauty, health and wellness spending

Beauty Health Elevates Monahan to Finance and Operations Chief

Beauty Health Q2 Earnings Call Highlights

The Beauty Health Company Q2 2026 Earnings Call Summary

Also Discussed

SkinHealth Systems Inc. Class A Common Stock

Company Information

Location

News

New research reveals a great divide in beauty, health & wellness, with executives and consumers at odds

Why more companies are fighting over consumers' beauty, health and wellness spending

Beauty Health Elevates Monahan to Finance and Operations Chief

Beauty Health Q2 Earnings Call Highlights

The Beauty Health Company Q2 2026 Earnings Call Summary

Also Discussed

Social

Jul 8

Sentiment

Bullish· Jul 7

Bearish· Nov 14

Topics

Feb 28

Community

Regulars· Mar 13

Newcomers· Mar 13